Botanical species · safety record

Lycoris rosea

The EFSA Compendium of Botanicals holds 3 constituent measurements for Lycoris rosea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lycoris rosea Traub & Moldenke

3Constituent measurements

0Safety records

1Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Galanthamine	Bulb / clove	Solvent extraction	≤ 836 Microgram/gram	GC-MS	No resolvable identifier
Lycorine	Bulb / clove	Solvent extraction	≥ 338 Microgram/gram	GC-MS	No resolvable identifier
Lycorine	Bulb / clove	Solvent extraction	≤ 923 Microgram/gram	GC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Guo, Ying., Pigni, Natalia B., Zheng, Yuhong., Paulo de Andrade, Jean., Torras-Claveria, Laura., de Souza Borges, Warley., Viladomat, Francesc., Codina, Caries., Bastida, Jaume. Analysis of Bioactive Amaryllidaceae Alkaloid Profiles in Lycoris Species by GC-MS . Natural product communications, 2014, vol. 9, no. 8, p. 1081-1086.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature